IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.615
NA - Nord America 1.024
EU - Europa 574
AF - Africa 25
SA - Sud America 25
OC - Oceania 12
Totale 6.275
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.650
US - Stati Uniti d'America 959
CN - Cina 506
HK - Hong Kong 353
GB - Regno Unito 143
IT - Italia 139
DE - Germania 81
NL - Olanda 61
CA - Canada 40
IN - India 37
FI - Finlandia 35
MX - Messico 24
AT - Austria 19
BR - Brasile 19
JP - Giappone 19
TR - Turchia 18
FR - Francia 15
PL - Polonia 15
AU - Australia 12
ES - Italia 12
UA - Ucraina 12
ZA - Sudafrica 11
EG - Egitto 9
LT - Lituania 9
DK - Danimarca 6
SE - Svezia 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
IL - Israele 4
VN - Vietnam 4
BG - Bulgaria 3
CO - Colombia 3
EE - Estonia 3
IR - Iran 3
RO - Romania 3
AR - Argentina 2
PH - Filippine 2
RU - Federazione Russa 2
TL - Timor Orientale 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
CH - Svizzera 1
EC - Ecuador 1
GH - Ghana 1
IE - Irlanda 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
YT - Mayotte 1
Totale 6.275
Salva come PNG Salva come JPEG
Città #
Hong Kong 348
Singapore 264
Hefei 256
Ashburn 182
Dallas 173
Boardman 135
London 120
Shanghai 81
Council Bluffs 73
Beijing 69
Amsterdam 51
Munich 50
Rome 41
Los Angeles 36
Turku 22
Santa Clara 21
Toronto 17
Ankara 16
San Francisco 16
Bari 15
Washington 15
Pune 14
Tokyo 14
Brooklyn 13
Mexico City 13
New York 13
Warsaw 13
Helsinki 12
Atlanta 11
Chennai 11
Hangzhou 10
Boston 9
Seattle 9
Chicago 8
Jinan 8
Nuremberg 8
Qingdao 8
West Jordan 8
Changsha 7
Guangzhou 7
Jaguariúna 7
Johannesburg 7
Montreal 7
Charlotte 6
Las Vegas 6
Melbourne 6
Naples 6
São Paulo 6
Milan 5
Paris 5
Pisa 5
Vienna 5
Brno 4
Chaozhou 4
Kongens Lyngby 4
Noicattaro 4
Secaucus 4
State College 4
Stockholm 4
Sydney 4
Xi'an 4
Chengdu 3
Ho Chi Minh City 3
New Delhi 3
Poplar 3
Redmond 3
Shijiazhuang 3
Tel Aviv 3
Alexandria 2
Anantapur 2
Bosco Marengo 2
Brest 2
Brisbane 2
Burlington 2
Cairo 2
Calgary 2
Cuernavaca 2
Denver 2
Dili 2
Fisciano 2
Frankfurt am Main 2
Groningen 2
Guiyang 2
Haikou 2
Herne Bay 2
Honolulu 2
Madrid 2
Manchester 2
Markham 2
Monterrey 2
Narashino Shi 2
Newark 2
Newcastle-under-Lyme 2
Philadelphia 2
Prayagraj 2
Quarto 2
Reus 2
Richmond 2
Rio de Janeiro 2
San Jose 2
Totale 2.389
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 198
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 196
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 194
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 189
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 184
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 177
Leptin in immuno-rheumatological diseases 170
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 169
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 164
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 163
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 150
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 136
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 123
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 118
Adult-onset Still's disease with elderly onset: results from a multicentre study 105
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 104
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 97
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 90
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 89
A longitudinal study on caring behaviors of Italian nursing students 88
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 87
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 86
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 86
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 86
Cannabinoids in Autoimmune and Rheumatic Diseases 85
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 85
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 85
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 83
Leptin in autoimmune mechanisms of systemic rheumatic diseases 82
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 79
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 76
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 66
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 65
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 64
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 61
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 60
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 56
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 45
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 45
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 43
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 41
Development and implementation of the AIDA International Registry for patients with Behçet's disease 38
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 38
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 37
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 35
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 34
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 33
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 33
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 32
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 32
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 32
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 31
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 31
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 31
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 30
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 30
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 29
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 29
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 29
Polypharmacy is a determinant of hospitalization in Parkinson's disease 29
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 28
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 28
Matters of the heart: The case of TNF-alpha targeting drugs 27
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 27
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 26
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 26
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 26
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 26
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 25
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 25
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 25
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 25
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 25
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 24
Utility of ultrasound in the diagnosis of chronic worsened gout 24
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 24
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 24
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 24
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art 24
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 24
Endothelial-to-mesenchymal transition in systemic sclerosis 24
Pathogenesis of Psoriatic Arthritis 23
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 23
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 23
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 23
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 23
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 23
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 22
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 22
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 22
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 21
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 21
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 21
Serum level of endostatin and digital ulcers in systemic sclerosis patients 21
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 21
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 21
Systemic lupus erythematosus patients with and without neuropsychiatric manifestations: a neck and transcranial duplex sonography study 21
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 20
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 20
Phase angle could be a marker of microvascular damage in systemic sclerosis 20
Totale 5.925
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/2026886 490 229 167 0 0 0 0 0 0 0 0 0
Totale 6.399